Type 2 diabetes mellitus, pandemic in 21st century
- PMID: 23393670
- DOI: 10.1007/978-1-4614-5441-0_6
Type 2 diabetes mellitus, pandemic in 21st century
Abstract
In the second half of the 20th century it became obvious that a relentless increase in Type 2 diabetes mellitus (T2DM), affecting the economically affluent countries, is gradually afflicting also the developing world. This chapter shows the threat that the T2DM epidemic represents to mankind, with the astonishing recent discoveries on the role of obesity and of body fat in this metabolic disorder. Presently, the highest prevalence of T2DM is in Saudi Arabia. T2DM is very high in over 10% of adults in the USA, Switzerland and Austria. Prevalence is low in Norway, China and in Iceland. Predictions of epidemiologists for the first third of the 21st century claim up to 2.5 times increase in the prevalence of T2DM in the Middle East, Sub-Saharan Africa, India, rest of Asia and in the Latin America. In China the number of patients with T2DM will double in 2030. In the economically advanced countries the increase will be about 50% in 2030. Increasing urbanization, aging populations, obesity and falling levels of physical activity are all contributing to the rise of T2DM worldwide. The main cause of T2DM pandemic is growing prevalence of obesity in Europe and USA. In the North America and European Union countries obesity is considered to be responsible for up to 70-90% of T2DM in adult population. The precise mechanism by which obesity leads to insulin resistance and to T2DM is not completely known but it may be related to several biochemical factors such as abnormalities in free fatty acids, adipokines, leptin and other substances.
Similar articles
-
Diabetes type 2 pandemic in 21st century.Bratisl Lek Listy. 2010;111(3):134-7. Bratisl Lek Listy. 2010. PMID: 20437822
-
Global prevalence and future of diabetes mellitus.Adv Exp Med Biol. 2012;771:35-41. doi: 10.1007/978-1-4614-5441-0_5. Adv Exp Med Biol. 2012. PMID: 23393669
-
Obesity, insulin resistance and diabetes--a worldwide epidemic.Br J Nutr. 2000 Mar;83 Suppl 1:S5-8. doi: 10.1017/s000711450000088x. Br J Nutr. 2000. PMID: 10889785 Review.
-
Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach.Diabetes Res Clin Pract. 2018 Mar;137:100-108. doi: 10.1016/j.diabres.2017.11.015. Epub 2017 Nov 22. Diabetes Res Clin Pract. 2018. PMID: 29175341
-
Type 2 diabetes mellitus and obesity in sub-Saharan Africa.Diabetes Metab Res Rev. 2010 Sep;26(6):433-45. doi: 10.1002/dmrr.1106. Diabetes Metab Res Rev. 2010. PMID: 20641142 Review.
Cited by
-
Effects of combined aerobic exercise and diet on cardiometabolic health in patients with obesity and type 2 diabetes: a systematic review and meta-analysis.BMC Sports Sci Med Rehabil. 2023 Dec 4;15(1):165. doi: 10.1186/s13102-023-00766-5. BMC Sports Sci Med Rehabil. 2023. PMID: 38049873 Free PMC article.
-
Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis.Diabetol Metab Syndr. 2023 Nov 28;15(1):245. doi: 10.1186/s13098-023-01202-x. Diabetol Metab Syndr. 2023. PMID: 38012781 Free PMC article. Review.
-
In vivo antioxidant and hypoglycaemic potentials of Rivina humilis extract against streptozotocin induced diabetes and its complications in wistar rats.J Diabetes Metab Disord. 2023 Aug 17;22(2):1373-1383. doi: 10.1007/s40200-023-01258-6. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975104
-
Folate deficiency may increase the risk for elevated TSH in patients with type 2 diabetes mellitus.BMC Endocr Disord. 2023 Aug 11;23(1):169. doi: 10.1186/s12902-023-01422-2. BMC Endocr Disord. 2023. PMID: 37563586 Free PMC article.
-
Recent Progress in Diboronic-Acid-Based Glucose Sensors.Biosensors (Basel). 2023 Jun 4;13(6):618. doi: 10.3390/bios13060618. Biosensors (Basel). 2023. PMID: 37366983 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
